Literature DB >> 2541545

Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins.

M S Lashgari1, H Tada, S Amini, K Khalili.   

Abstract

To better understand the basis of cell type specificity of JCV replication, we have analyzed the expression of the viral late promoter in glial cells. Using transient transfection procedures, we show that the late gene expression, like that of the early gene, is restricted to glial cells. However, cotransfection with a plasmid producing the JCV early protein, T-antigen, stimulates expression from the JCV late promoter in both glial and non-glial cells. The SV40-encoded T-antigen acts similarly on transcription of JCV late promoter in both cell types. This transacting effect occurs at the level of RNA synthesis, as measured by the rate of transcription, stability of the message, and translation. These results indicate that basal JCV late promoter activity is restricted to glial cells, whereas in the presence of viral early protein this promoter functions in both glial and non-glial cells.

Mesh:

Substances:

Year:  1989        PMID: 2541545     DOI: 10.1016/0042-6822(89)90381-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells.

Authors:  M Safak; R Barrucco; A Darbinyan; Y Okada; K Nagashima; K Khalili
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

3.  Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication.

Authors:  A Sami Saribas; Sarah Mun; Jaslyn Johnson; Mohammad El-Hajmoussa; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

4.  Functional comparison of PML-type and archetype strains of JC virus.

Authors:  E Sock; K Renner; D Feist; H Leger; M Wegner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 5.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Immune suppression of JC virus gene expression is mediated by SRSF1.

Authors:  Rahsan Sariyer; Francesca Isabella De-Simone; Jennifer Gordon; Ilker Kudret Sariyer
Journal:  J Neurovirol       Date:  2016-03-07       Impact factor: 2.643

7.  JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2012-07-27       Impact factor: 3.616

8.  Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha.

Authors:  C F Chang; G L Gallia; V Muralidharan; N N Chen; P Zoltick; E Johnson; K Khalili
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 9.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

10.  Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen.

Authors:  Ilker K Sariyer; Kamel Khalili; Mahmut Safak
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.